To prove HCP5 regulates the radiosensitivity of esophageal carcinoma by miR-216a-3p/PDK1 axis, the miR-216a-3p inhibitor was performed in rescue experiments (Figure 5(a)). Here, HCP5 is linked to carcinoma of esophagus.